For research use only. Not for therapeutic Use.
DNAC-1(Cat No.:I026395)is a small-molecule compound that has shown promise as a therapeutic agent in cancer research. It functions as an inhibitor of certain key proteins involved in tumor growth and metastasis, particularly those within the DNA damage response and cell cycle regulation pathways. DNAC-1 has demonstrated potential in selectively targeting cancer cells, inducing apoptosis, and inhibiting tumor proliferation. Early preclinical studies suggest that DNAC-1 could be effective in treating various types of cancers, making it a candidate for further development in oncology, especially in combination with other treatments.
Catalog Number | I026395 |
CAS Number | 1006021-30-2 |
Synonyms | DNAC-1; DNAC 1; DNAC1; |
Molecular Formula | C11H9BrN2S2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 5-(5-bromo-3,4-dimethylthieno[2,3-b]thiophen-2-yl)-1H-pyrazole |
InChI | InChI=1S/C11H9BrN2S2/c1-5-8-6(2)10(12)16-11(8)15-9(5)7-3-4-13-14-7/h3-4H,1-2H3,(H,13,14) |
InChIKey | MUNXAASMRMRSCE-UHFFFAOYSA-N |
SMILES | CC1=C(SC2=C1C(=C(S2)Br)C)C3=CC=NN3 |